Tripodi, A <br/><br/>
New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation.  [electronic resource] 

 -  Journal of internal medicine  Jun 2012 
 - 554-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1365-2796 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2796.2012.02541.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticoagulants--therapeutic use<br/>Atrial Fibrillation--complications<br/>Benzimidazoles--pharmacology<br/>Clinical Trials as Topic<br/>Clinical Trials, Phase III as Topic<br/>Dabigatran<br/>Drugs, Investigational<br/>Heparin--therapeutic use<br/>Humans<br/>International Normalized Ratio<br/>Morpholines--pharmacology<br/>Pyrazoles--pharmacology<br/>Pyridones--pharmacology<br/>Rivaroxaban<br/>Stroke--etiology<br/>Thiophenes--pharmacology<br/>Treatment Outcome<br/>Venous Thromboembolism--etiology<br/>Vitamin K--antagonists & inhibitors<br/>beta-Alanine--analogs & derivatives